chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient reports that roughly 72 hours after first dose of MODERNA COVID-19 vaccine, he developed pain, redness, and swelling in his left ankle (with notable history of prior ORIF with hard ware in this ankle). It was initially treated as potential gout through the Emergency Room with low dose prednisone burst. Symptoms did not improve and was later given Keflex 500mg PO Q6hr for possible cellulitis in setting of tinea pedis. First dose of vaccine was 29Jan2021.   Patient had second dose of MODERNA COVID-19 vaccine on 26Feb2021. About 48 hours after vaccination, he reported worsened swelling and redness at his left ankle (in setting of improvement since starting antibiotics). The recurrence of redness and swelling started to improve about 6 days later, where he came back to Internal medicine clinic for repeat evaluation.
Client contacted writer today, Nov. 28, 2017 and reported she has experienced severe pain since getting her flu shot on Oct. 20th. She felt that the pain was more than it should be one week after receiving the vaccine. She had an X-ray today, has gone to a chiropractor 3 times and saw her physician today and he gave her anti-inflammatiry medication. (Mobic) He also ordered P.T.
Been a year since my 1st shot, can I get my 2nd?; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received a year before the date of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 18-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient reported that it had been a year since first Shingrix shot and asked if he or she could get the 2nd dose now. Additional Supportive Information: Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Patient received dose 1 of GARDASIL and had not received more doses; no adverse event; This spontaneous report was received from a pharmacist doctor referring to a 42 year old patient of unspecified gender.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.      On 24-JUL-2020 the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) dose 1 for prophylaxis.  It was reported that the patient did not know that hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) required additional doses and so had not received the complete scheme (inappropriate schedule of product administration).  There was no other adverse event reported.
Hearing problem; 1st vaccine in March, wanted to find out if can get the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Hearing problem) and PRODUCT DOSE OMISSION ISSUE (1st vaccine in March, wanted to find out if can get the 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (Hearing problem) and PRODUCT DOSE OMISSION ISSUE (1st vaccine in March, wanted to find out if can get the 2nd dose). At the time of the report, HYPOACUSIS (Hearing problem) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (1st vaccine in March, wanted to find out if can get the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Discharge Physician: MD, MPH Primary Care Physician: MD  Date of Admission: 4/2/2023 Discharge Date: 4/3/2023 Room Number:  PRESENTING PROBLEM: Shortness of breath [R06.02] Pleural effusion [J90] Chest pressure [R07.89] Hypoxia [R09.02] Acute decompensated heart failure [I50.9] Acute on chronic diastolic (congestive) heart failure [I50.33] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 85 y.o. very pleasant female who presents to ER today with worsening dyspnea over last few days, Chest pressure - pleuritic, new nonproductive cough, new onset orthopnea, last 2 nights couldn't sleep, barely can walk 6 feet with severe dyspnea. Edema in LE are improving.  Denies fever, chills, n/v, diarrhea, myalgias.  Reports improvement in LLE knee pain and swelling.  Patient's PCP referred her to the emergency room for further evaluation.   In the ED she was +COVID19 and did not require supplemental oxygen. She was noted to be hypoxic with exertion only. She was started on IV diuresis and continued on IV antibiotics. Patient had good urine output and improvement of symptoms. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Within 10 minutes of vaccination patient developed vomiting closely followed by irritability and hives. At about 1230 patient developed circumoral cyanosis and hypoxia. 1248 swelling to left thigh. 1302 hives gone but skin red from knees to head (patient received 7.5 mg Benadryl, blow-by oxygen and was admitted for observation).
This spontaneous report as received from a pharmacist refers to a 2 months old patient (gender not reported). The patient was vaccinated with a dose of PNEUMOVAX23. Route, dose and lot number were not reported. No adverse symptoms were reported. Additional information has been requested.
I fainted within 5 minutes of receiving it. Ambulance was called to check me out. Had a headache the rest of the evening, then off and on for the 2 following days. Feeling nauseous off and on for the following 2 days, too.
After more than a month of taking the 2nd shot of Covid Pfizer vaccine I started having some lingering cough then in 3 weeks developed rashes on body. Family doctor thought allergies. Also found BP shot up to 144/95 and heart palpitations with high resting heart beats (144) existed (never had high BP or such resting high heart beats before!). Started BP medication and also took allergy medication for a week. No help. Then started getting out of breathe when taking walks for 30 minutes (used to be fine before!). Again went to family doctor. She did breathing test and that came quite low. Doctor suggested chest X-ray. It revealed double pneumonia even though I didn't have any fever. Took two courses of anti biotics but didn't help. Then went to a lung specialist (Pulmonologist). They found my blood oxygen saturation levels were falling to dangerous levels (mid to high 80s).  He suggested another chest X-ray and also CT scan and blood tests. No improvement was seen between the two X-rays. CT revealed lung infection. Dr. suggested to see a Rheumatologist for further diagnosis. Rheumatologist suggested additional panel of blood tests and mentioned by those there may be lung disease that is causing getting out of breathe! Diagnosis is currently in progress. Saw advanced Pulmonologist at hospital who have suggested immediate lung biopsy to figure out the state of lungs and to determine the right course of medication. That is currently being scheduled! I am currently on high dosage of Steroids, BP medication, antibiotic (to avoid pneumonia), inhaler, acidity medication. I am prescribed oxygen concentrator currently and can't do any normal household chores (cooking, taking bath, climbing steps, etc.) without oxygen tube as my blood oxygen goes down again!  Lastly I wanted to say that I have been very healthy all my life with no prescription medication whatsoever, doing regular exercise during pandemic lockdown and took all precautions to not contract Covid but I strongly believe that taking the two Covid vaccine shots got me to this state!!!!
Covid arm which is huge and bubbly; chest pain; Feels like she  needs air which is similar to air hunger.; nerves are  firing; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm which is huge and bubbly), CHEST PAIN (chest pain), DYSPNOEA (Feels like she  needs air which is similar to air hunger.), BURNING SENSATION (nerves are  firing) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included MS (MS patient (an autoimmune disease).) and Immunocompromised.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm which is huge and bubbly), CHEST PAIN (chest pain), DYSPNOEA (Feels like she  needs air which is similar to air hunger.), BURNING SENSATION (nerves are  firing) and CHILLS (chills). At the time of the report, VACCINATION SITE REACTION (Covid arm which is huge and bubbly), CHEST PAIN (chest pain), DYSPNOEA (Feels like she  needs air which is similar to air hunger.), BURNING SENSATION (nerves are  firing) and CHILLS (chills) outcome was unknown.            Patient concomitant product included 20mg of steroids No treatment information was provided.
I received the Covid vaccine on 3/9/2021 and was exposed to the Covid virus around March 31.  I tested positive for Covid on 4/6/2021.  I had runny nose, low grade fever thinking it was seasonal allergies until April 5 when my temperatures was 102.  My Granddaughter tested positive on April 5 and so did her mother.  I immediately notified my Doctor that I was positive and his office immediately made arrangements for me to be given Monoclonal Antibody Therapeutics.  I was hospitalized January 2020 with shortness of breathe, pulse ox 72, temperature 104.  At that time I was told I had a virus of some kind but the Doctor in the hospital was not sure what kind.
Patient called clinic today stating she has hives to face and feels this is from flu vaccine received 9/29/09 at clinic. Patient states she "felt funny" last night after vaccine received.Patient advised to use claritin.zyrtec during day and benadryl at night.Patient to see MD if increased problems.
Patient had syncopal episode within 15 minutes of vaccination.  Felt better after drinking some juice and was released to home.
A non-serious spontaneous report of shingles has been received from a physician concerning his 48-year-old wife subsequent to H1N1, Intranasal vaccination. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient was in good health prior to vaccination. On 14-Nov-2009, the patient received H1N1, Intranasal for an unknown indication. On 17-Nov-2009, the patient reported pain and rash in the dermatomal distribution consistent with shingles. No fever, no constitutional symptoms for the patient. No other history or physical findings. Shingles were diagnosed. No laboratories were obtained. The outcome of the event was unknown.
This spontaneous report was received from a physician referring to an unknown number of patients of unknown gender and age. Pertinent medical history or concurrent conditions were not reported. Since 30-MAY-2017 (also reported as since 10-APR-2017), the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB which had the lot # reported as N00236, expiration date 24-OCT-2019, lot # N000235, expiration date 26-OCT-2019, lot # N003536, expiration date 02-NOV-2019, for prophylaxis (dosage information and route were not informed). Information regarding concomitant medication was not provided. Additionally, it was reported that the lowest temperature was 32 degrees Fahrenheit and the highest was 54 degrees Fahrenheit for 49 hours. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. Follow-up information has been received from a physician on 16-OCT-2017 to an unknown number of patients of unknown gender and age. The patients' concomitant medications, pertinent medical history, drug reactions or allergies were not reported. Since 29-APR-2017 (also reported as since 10-APR-2017), the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot # M046140, expiration date 27-SEP-2019, dosage information and route were not provided) for prophylaxis. Additionally, it was reported that the lowest temperature was 47 degrees Fahrenheit and the highest was 49 degrees Fahrenheit for 16 hours. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. Follow up was received from the physician on 30-OCT-2017, regarding a 4-month-old patient, who on 09-AUG-2017, received a dose of improperly stored LIQUID PEDVAXHIB injection, lot # N000235 with expiration date on 26-OCT-2019. The vaccine underwent a temperature excursion of 32-49 degrees Fahrenheit for 492 hours. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-1709USA012767: US-009507513-1709USA012768:
This spontaneous report as received from a 21 year old female consumer refers to herself. The patient reported that on 19-JUN-2014 she went to her OBGYN for the second injection of GARDASIL (lot#, dose, route not reported). Concomitant therapy was not reported. The patient started having an adverse reaction as soon as she received the injection with her arm starting to go through spasms. After leaving the physician's office, the patients started experiencing nausea, and severe pain in her arm, shoulder, neck and back and she also started having chills while driving her car. The side of her face became numb and her legs were weak. The patient was currently going to Urgent Care for an evaluation. At time of the report, outcome of the events was reported as not recovered. Additional information has been requested.
Near syncope episode after receiving Tdap, MMR, and varicella. C/o of dizziness and nausea. No loss of consciousness. Patient reported fasting for the day prior to vaccine administration. Vital signs monitored, oral fluids given, symptoms self resolved.
Information has been received from a healthcare worker referring to a female patient of unknown age. On an unknown date in 2015 (reported as "within the past 2 weeks) the patient was vaccinated with an improperly stored dose of GARDASIL (strength, dosage and frequency unspecified) lot # K006117, expiration date: 14-JAN-2017, intramuscularly as her third dose in the series. No adverse effect was reported. Additional information has been requested.
Initial report was received from a health care professional on 21 September 2011. A 65-year-old female patient had received a FLUZONE HIGH-DOSE injection in left deltoid, lot number UH439AA on 15 September 2011. Six hours after vaccination the patient developed chills, diarrhea, neck and joint pain, sinus pain and vomiting. No further information was available at the time of the report. The patient's outcome was recovered/resolved. Follow-up information was received on 03 January 2012 from a health care professional. The patient recovered on 17 September 2011. Documents held by sender: none.
Headache L deltoid pain, body ache, chills, itchy throat, metallic taste Narrative:
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium
Increased problems with speech, finding words, and confusion. Cannot answer the phone anymore. She seems to be more needy, shuffles (new onset), and incontinence problem has returned. Did not have an office visit as a result of adverse event.
lymph nodes of armpit where the vaccine was administered are really sore; Lymph nodes of armpit where the vaccine was administered are really sore; Mild symptoms; Felt dizzy after the administration; Had a little bit of every symptoms but mild; A spontaneous report was received from a consumer concerning herself, who is a 41-years-old female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events mild symptoms, felt dizzy after the administration, had a little bit of every symptoms but mild, lymph nodes of armpit where the vaccine was administered are really sore.  The patient's medical history was not provided. Concomitant medications reported were aderol for drug use for unknown indication.  On 06 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012M20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 06 Feb 2021, the patient experienced the events mild symptoms, felt dizzy after the administration, pretty much had a little bit of every symptoms but mild. What bothers her is that the lymph nodes of armpit where the vaccine was administered are really sore.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events mild symptoms, felt dizzy after the administration, had a little bit of every symptoms but mild, lymph nodes of armpit where the vaccine was administered are really sore was unknown.
Vaccine administered beyond Expiration date. However, per  Moderna- all vaccines met viability requirements.  Completing VAERS per requirements.
headache; slight fever; some swelling in a lymph node in the armpit near the arm of injection; This is a spontaneous report from a non-contactable consumer (patient) communicated to a Pfizer sales representative. A 48-years-old male patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date (at the age of 48-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified dose on an unspecified date (at the age of 48-years-old) for COVID-19 immunisation. On an unspecified date, the patient experienced headache, slight fever and some swelling in a lymph node in the armpit near the arm of injection after the administration of the second dose. Outcome of events were unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
The patient developed neck swelling and pain on the side of the injected deltoid muscle approx 24 hours after injection. She then developed swelling and pain in the left axilla about 72 hours after injection. She has had no skin reaction and no reaction at the site of the injection. She denies numbness, tingling, weakness. She has no history of immunization/vaccine reaction. Her last tetanus toxoid administration was over 10 years prior.
pt recvd vax 1JAN93 & 16 to 24 hrs following inject pt exp malaise, fatigue & sx of an upper resp infect (URI); No further details were provided;
Writer is completing VAERS as Writer unclear if previously completed. Writer was giving influenza shot to Patient on 9/22/22 and reviewed previous vaccine reactions with Patient and was not noted on Patient's allergy/intolerance list.  Patient developed high fever (over 102F per patient/family) and weakness (unable to ambulate) in the middle of the night the day 2/12/2021 following vaccination. Patient ended up being hospitalized for 2 days and per hospital discharge summary Patient had febrile illness felt to be related to Moderna vaccination and presented with fever, weakness, body aches, with 101.2F during hospitalization, and Patient had negative infectious disease work up. Fever subsided, weakness improved but in home physical therapy was ordered upon hospital discharge, and body aches resolved. Patient was discharged 2/13/2021.  Patient later decided to proceed with Moderna 50 mcg booster dose #3 (Lot #039F21A, given at Pharmacy on 11/15/2021 with similar symptoms developing the following day after vaccination 11/16/2021 including weakness and fever up to 102.5 F, but symptoms subsided 11/17/22 and Patient/family able to manage symptoms at home. Writer had initially noted in immunization records 11/15/2021 dose was documented as 100 mcg Moderna dose "full" dose, but Writer called Pharmacy on 10/16/22 and verified actually Patient received Moderna 50 mcg dose  booster dose "half dose" for dose #3 and Pharmacist updated immunization records accordingly. Patient received correct dose #3 COVID-19 Vaccination, Patient did not meet moderately immunocompromised criteria.